Connect with us

Business

Rhythm (ASX:RHY) share price surges 10% on ColoSTAT results

Published

on

The Rhythm Biosciences Ltd (ASX: RHY) share price is a strong mover today following the release of its ColoSTAT results.

Rhythm’s ColoSTAT is an experimental test-kit that is being trialled as a low-cost, easy-to-use blood test to detect colorectal cancer.

At the time of writing, the…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
MLC Centre food court, Birkenhead Point Brand Outlet among venues on alert for COVID in NSW – 7NEWS.com.au
2 excellent mid cap ASX shares rated as buys